Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
David Ricks
Fierce Pharma
Lilly, Boehringer slash investment plans in Germany
In response to a healthcare reform initiative in Germany, Lilly and Boehringer have slashed their planned investments there, each by at least $1B.
Kevin Dunleavy
Jun 3, 2026 3:10pm
'All hands on deck' at Lilly as peers target obesity market
Aug 8, 2024 1:40pm
Lilly CEO David Ricks to biotechs: 'We're open for business'
Jan 9, 2024 7:04pm
Winner crowned in Alzheimer's contest between Aduhelm and Lilly
Dec 1, 2022 5:30am
Roche, Biogen temper Alzheimer's expectations in Q2 calls
Jul 22, 2022 9:07am
Final Aduhelm ruling keeps the door cracked open in Alzheimer's
Apr 8, 2022 8:46am
